| Item Type | Name |
|
Concept
|
Graft vs Host Disease
|
|
Academic Article
|
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.
|
|
Academic Article
|
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.
|
|
Academic Article
|
Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.
|
|
Academic Article
|
Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease.
|
|
Academic Article
|
A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801.
|
|
Academic Article
|
Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups.
|
|
Academic Article
|
Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy.
|
|
Academic Article
|
Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation.
|
|
Academic Article
|
Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium.
|
|
Academic Article
|
Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival.
|
|
Academic Article
|
Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease.
|
|
Academic Article
|
Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study.
|
|
Academic Article
|
Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation.
|
|
Academic Article
|
Assessment of joint and fascia manifestations in chronic graft-versus-host disease.
|
|
Academic Article
|
A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.
|
|
Academic Article
|
Relationship of body mass index and arm anthropometry to outcomes after pediatric allogeneic hematopoietic cell transplantation for hematologic malignancies.
|
|
Academic Article
|
A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus-Host Disease.
|
|
Academic Article
|
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.
|
|
Academic Article
|
Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease.
|
|
Academic Article
|
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.
|
|
Academic Article
|
Bandage Soft Contact Lenses for Ocular Graft-versus-Host Disease.
|
|
Academic Article
|
Failure-free survival after initial systemic treatment of chronic graft-versus-host disease.
|
|
Academic Article
|
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
|
|
Academic Article
|
Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease.
|
|
Academic Article
|
Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on Immunosuppression.
|
|
Academic Article
|
Treatment of chronic graft-versus-host disease: Past, present and future.
|
|
Academic Article
|
Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.
|
|
Academic Article
|
Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.
|
|
Academic Article
|
Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Prediction of outcomes after second-line treatment for acute graft-versus-host disease.
|
|
Academic Article
|
Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.
|
|
Academic Article
|
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.
|
|
Academic Article
|
Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.
|
|
Academic Article
|
Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome.
|
|
Academic Article
|
Validation of measurement scales in ocular graft-versus-host disease.
|
|
Academic Article
|
Management of acute graft-versus-host disease in children.
|
|
Academic Article
|
ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.
|
|
Academic Article
|
Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease.
|
|
Academic Article
|
Cevimeline reduced mouth dryness and increased salivary flow in patients with xerostomia complicating chronic graft-versus-host disease.
|
|
Academic Article
|
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.
|
|
Academic Article
|
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
|
|
Academic Article
|
Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia.
|
|
Academic Article
|
Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease.
|
|
Academic Article
|
Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia.
|
|
Academic Article
|
Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.
|
|
Academic Article
|
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.
|
|
Academic Article
|
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.
|
|
Academic Article
|
Resilience, health, and quality of life among long-term survivors of hematopoietic cell transplantation.
|
|
Academic Article
|
Diagnosis and clinical management of chronic graft-versus-host disease.
|
|
Academic Article
|
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.
|
|
Academic Article
|
Duration of immunosuppressive treatment for chronic graft-versus-host disease.
|
|
Academic Article
|
Replication of associations between genetic polymorphisms and chronic graft-versus-host disease.
|
|
Academic Article
|
Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial.
|
|
Academic Article
|
A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.
|
|
Academic Article
|
Late effects of chronic graft-versus-host disease.
|
|
Academic Article
|
Secondary treatment of acute graft-versus-host disease: a critical review.
|
|
Academic Article
|
Late infectious complications in hematopoietic cell transplantation survivors: a population-based study.
|
|
Academic Article
|
Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia.
|
|
Academic Article
|
Adjunctive Dietary Therapy Is Associated With Improved Gastrointestinal Symptoms in Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease: A Case Series.
|
|
Academic Article
|
Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.
|
|
Academic Article
|
Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission.
|
|
Academic Article
|
Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease.
|
|
Academic Article
|
Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation Survivors.
|
|
Academic Article
|
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.
|
|
Academic Article
|
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease.
|
|
Academic Article
|
Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.
|
|
Academic Article
|
Success of allogeneic marrow transplantation for children with severe aplastic anaemia.
|
|
Academic Article
|
Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease.
|
|
Academic Article
|
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.
|
|
Academic Article
|
Clinical benefit of response in chronic graft-versus-host disease.
|
|
Academic Article
|
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.
|
|
Academic Article
|
Genetic risk factors for sclerotic graft-versus-host disease.
|
|
Academic Article
|
Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
|
|
Academic Article
|
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
|
|
Academic Article
|
How I conduct a comprehensive chronic graft-versus-host disease assessment.
|
|
Academic Article
|
HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide.
|
|
Academic Article
|
Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.
|
|
Academic Article
|
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.
|
|
Academic Article
|
Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome.
|